220640-14-2

Basic information

• Product Name: N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl)
• Synonyms: N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl);methyl-tetrahydrothiopyran-4-yl-amine;N-methyl-4-tetrahydrothiopyranamine;N-methyltetrahydrothiopyran-4-amine;N-methylthian-4-amine;N-methyltetrahydro-2H-thiopyran-4-amine
• CAS NO: 220640-14-2
• Molecular Formula: C6H14ClNS
• Molecular Weight: 167.70006
• Mol File: 220640-14-2.mol

Chemical Properties

• Boiling Point: 203.7±33.0 °C(Predicted)
• Appearance: /
• Density: 0.99±0.1 g/cm3(Predicted)
• PKA: 9.94±0.20(Predicted)
• CAS DataBase Reference: N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl)(220640-14-2)
• EPA Substance Registry System: N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl)(220640-14-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 220640-14-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
N-methyltetrahydro-2H-thiopyran-4-amine(SALTDATA: HCl) is employed as a potential therapeutic agent in pharmaceutical research. Its unique structure and properties make it a candidate for the development of new drugs to treat a range of medical conditions. Further research is necessary to fully understand its potential applications and to ensure its safety and efficacy in clinical settings.
As the provided materials do not specify particular industries or detailed applications beyond pharmaceutical research, the uses listed above are based on the general information given. Further investigation into the compound's properties and potential applications would be required to expand on its uses in specific industries or for particular purposes.

Upstream product

• 1072-72-6 Tetrahydrothiopyran-4-one 
• 74-89-5 methylamine 

Relevant articles and documents

Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors

The disclosure relates to compounds of formula (I): wherein R1-R5, A and Y are as defined in the disclosure, to compositions comprising said compounds, and to processes for making and methods of using the same.

CARBAMATE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

The invention provides novel benzoimidazolone-carboxamide-derived carbamate 5-HT4 receptor agonist compounds of formula (I): wherein R1, R2, R3, R4, a, and b are defined in the disclosure. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Quinolinone-carboxamide compounds

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Indazole-carboxamide compounds

The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

5-HT4 receptor agonist compounds

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Quinolinone compounds as 5-HT4 receptor agonists

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Substituted herbicide tetrazolinonecarboxylic acid amides

Tetrazolinonecarboxamides of formula I wherein Het is oxetan-3-yl, thietan-3-yl, tetrahydrofuran-3-yl, furan-3-yl, tetrahydrothiophen-3-yl, thiophen-3-yl, tetrahydro-2H-pyran-3-yl, tetrahydro-2H-thiopyran-3-yl, tetrahydro-2H-pyran-4-yl or tetrahydro-2H-th